Relationship between insulin-like growth factor-I and brain natriuretic peptide in patients with acromegaly after surgery

Circulation Journal

Volumn 71, Issue 12, 2007, Pages 1955-1957

  Ito, Masahiro ^a,b   Kodama, Makoto ^a   Tsumanuma, Itaru ^a   Ramadan, Mahmoud M ^a   Hirayama, Satoshi ^a   Kamimura, Takashi ^a   Kashimura, Takeshi ^a   Fuse, Koichi ^a   Hirono, Satoru ^a   Okura, Yuji ^a   Aizawa, Yoshifusa ^a  

^a Niigata University   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Acromegaly; Brain natriuretic peptide; Insulin like growth factor I

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; PROTEIN BLOOD LEVEL;

ACROMEGALY; CARDIOTONIC AGENTS; ENDOMYOCARDIAL FIBROSIS; FEMALE; HEART VENTRICLES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 37149021750     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1955     Document Type: Article

References (20)

1. Saetrum Opgaard O, Wang PH. IGF-I is a matter of heart. Growth Harm IGF Res 2005; 15: 89-94.
2. Ceci M, Ross J Jr, Condorelli G. Molecular determinants of the physiological adaptation to stress in the cardiomyocyte. J Mol Cell Cardiol 2004; 37: 905-912.
3. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, et al. Criteria for cure of acromegaly. J Clin Endocrinol Metab 2000; 85: 526-529.
4. Sacca L, Napoli R, Cittadini A. Growth hormone, acromegaly, and heart failure. Clin Endocrinol 2003; 59: 660-671.
5. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyaina K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
6. Cicoira M, Rossi A, Bonapace S, Zanolla L, Golia G, Franceschini L, et al. Independent and additional prognostic value of amino terminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail 2004; 10: 403-411.
7. Neri Serneri GG, Modesti PA, Boddi M, Cecioni I, Paniccia R, Coppo M, et al. Cardiac growth factors in human hypertrophy: Relations with myocardial contractility and wall stress. Circ Res 1999; 85: 57-67.
8. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study. Ann Intern Med 2003; 139: 642-648.
9. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease. Circulation 2002; 106: 939-944.
10. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, et al. Increased cardiac sympathetic activity and insulin-like growth factor-1 formation arc associated with physiological hypertrophy in athletes. Circ Res 2001; 89: 977-982.
11. Koziris LP, Hickson RC, Chatterton RT Jr, Groseth RT, Christie JM, Goldflies DG, et al. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 1999; 86: 1436-1442.
12. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110α) pathway. J Biol Chem 2004; 279: 4782-4793.
13. Bollano E, Bergh CH, Kjellstrom C, Omerovic E, Kujacic V, Caidahl K, et al. Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats. Eur J Heart Fail 2001; 3: 651-660.
14. Shiojima I, Sato K, Izumiya Y, Schickofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005; 115: 2108-2118.
15. Abe N, Matsunaga T, Kameda K, Tomita H, Fujiwara T, Ishizaka H, et al. Increased level of pericardial insulin-like growth factor-I in patients with left ventricular dysfunction and advanced heart failure. J Am Coll Cardiol 2006; 48: 1387-1395.
16. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 264-272.
17. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, et al. Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study. J Clin Endocrinol Metab 1999; 84: 1518-1523.
18. Delaughter MC, Taffet GL, Fiorotto ML, Entman ML, Schwartz RJ. Local insulin-like growth factor f expression induces physiologic. then pathologic, cardiac hypertrophy in transgenic mice. FASEB J 1999; 13: 1923-1929.
19. Meyers DE, Cuneo RC. Controversies regarding the effects of growth hormone on the heart. Mayo Clin Proc 2003; 78: 1521-1526.
20. Wallaschofski H, Saller B, Spilcke-Liss E, Lerch MM, Lohmann T, Eigenthaler M. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency. Horm Metab Res 2006; 38: 656-661.